Trial Profile
Phase IIa Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of M2951 in Subjects With Rheumatoid Arthritis on Stable Methotrexate Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Evobrutinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors EMD Serono
- 27 Nov 2017 Status changed from active, no longer recruiting to completed.
- 25 May 2017 Planned End Date changed from 1 Oct 2017 to 14 Nov 2017.
- 27 Feb 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017.